CoreWeave Prices Upsized $3.7B Convertible Notes as Stock Slides Amid Funding Risks

CoreWeave (CRWV) priced $3.7 billion aggregate principal amount of 2.875% convertible senior notes due 2033, upsized from the $3.0 billion offering it proposed the previous day. The initial conversion rate is 10.2194 shares per $1,000 of principal, an initial conversion price of about $97.85 and a 22.50% premium to the September 17 close. The notes mature April 1, 2033 and settle September 22, and the deal carries a $500 million over-allotment option that was unexercised at pricing, which would take it to $4.2 billion if taken up.

Two instruments were announced together on September 17 and are easy to conflate. One is this convertible notes offering. The other is a separate at-the-market program covering the sale of up to 35 million shares, which is equity, not debt. The market read the combination as dilution plus leverage: the shares fell about 4.2% to $79.88 that day. The move on the pricing day itself was far smaller.

The financing lands on a stock that has already de-rated. CoreWeave is down 17.4% over the past three months as investors weigh the capital intensity of its GPU cloud buildout against the revenue it is winning. Not everyone reads it as a warning: Rosenblatt Securities analyst John McPeake reiterated a Buy rating with a $250 price target after the pricing update. Note that the publishers carrying that call are wire carriers; Rosenblatt is the firm that took the action.

The question the notes raise is how much of the buildout is now pre-funded and at what cost. A 2.875% coupon is cheap money by the standards of an unprofitable infrastructure scale-up, and the conversion price of $97.85 sits well above the current share price, so the dilution is deferred rather than immediate. What to watch from here is whether the over-allotment gets exercised, how quickly the at-the-market program is drawn down, and what management says about cash interest and capex phasing at the next results.